Compare PUK & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PUK | KVUE |
|---|---|---|
| Founded | 1848 | 2022 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Specialty Chemicals |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 33.1B |
| IPO Year | 1990 | 2023 |
| Metric | PUK | KVUE |
|---|---|---|
| Price | $33.66 | $17.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $19.58 |
| AVG Volume (30 Days) | 808.4K | ★ 48.6M |
| Earning Date | 03-18-2026 | 02-17-2026 |
| Dividend Yield | 1.40% | ★ 4.72% |
| EPS Growth | ★ 307.39 | 35.31 |
| EPS | ★ 1.30 | 0.75 |
| Revenue | $13,342,000,000.00 | ★ $15,006,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.11 | $2.72 |
| P/E Ratio | $25.81 | ★ $23.52 |
| Revenue Growth | ★ 21.91 | N/A |
| 52 Week Low | $16.24 | $14.02 |
| 52 Week High | $33.92 | $25.17 |
| Indicator | PUK | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 68.17 | 63.96 |
| Support Level | $32.84 | $17.14 |
| Resistance Level | $33.92 | $17.89 |
| Average True Range (ATR) | 0.53 | 0.37 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 87.25 | 86.26 |
Originally established as Prudential Mutual Assurance, Investment, and Loan Association in 1848, Prudential plc has moved on a lot since then. Set up to sell life insurance and loans to the middle and then the industrializing and urbanizing working classes, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life in around 1985. During its time as owner of Jackson, Prudential focused on building out a simple chassis-style product portfolio where customers could choose a variety of add-ons. The company also became renowned for its focus on building requisite internal capabilities to support its strong product offerings, including compelling technology and a large and well-trained wholesale sales.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.